NEW YORK, NY / ACCESSWIRE / July 4, 2018 / U.S. equities dropped on Tuesday, as gains in energy, real-estate and telecom shares were offset by losses in tech and financial names. The Dow Jones Industrial Average decreased 0.54 percent to close at 24,174.82, while the S&P 500 Index shed 0.49 percent to close at 2,713.22. The Nasdaq Composite Index have fallen 0.49 percent to close at 7,502.67.
Managing director of sales and trading at Themis Trading, Mark Kepner said, “There is not much pure information that would be moving the market, but when trading volumes are low, like today, any piece of news can exaggerate moves.”
RDI Initiates Coverage on:
Lam Research Corporation
Lam Research's stock moved 3.35% lower Tuesday, to close the day at $167.25. The stock recorded a trading volume of 2,048,308 shares, which was below its three months average volume of 3,525,423 shares. In the last year, Lam Research's shares have traded in a range of 139.24 - 234.88. The share price has gained 20.12% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $189.42 is below its 200-day moving average of $194.44. Shares of the company are trading at a Price to Earnings ratio of 16.26. Shares of Lam Research have fallen roughly 17.48 percent in the past month and are down 9.14 percent year-to-date.
Access RDI's Lam Research Corporation Research Report at:
On Tuesday, shares of Cree recorded a trading volume of 1,664,151 shares, which was above the three months average volume of 1,268,009 shares. The stock ended the day 4.96% higher at $43.63. The share price has fallen 13.91% from its 52 week high with a 52 week trading range of 20.50 - 50.68. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $46.73 is above its 200-day moving average of $40.57. Shares of Cree have fallen roughly 7.8 percent in the past month and are up 17.47 percent year-to-date.
Access RDI's Cree, Inc. Research Report at:
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
For any questions, inquiries, or comments reach out to us directly at:
Address: Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.